Oxford BioMedica PLC (OXB) — Cash Flow Quality Index

Latest as of December 2021: 2.53x

Oxford BioMedica PLC (OXB) has a Cash Flow Quality Index of 2.53x as of December 2021. Operating cash flow of GBX2.38 Million exceeds net income of GBX942.00K, indicating high earnings quality where cash backs reported profits. Explore Oxford BioMedica PLC strategic investment ratio to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

2.53x
Operating CF / Net Income

Operating Cash Flow

GBX2.38 Million
GBX

Net Income

GBX942.00K
GBX

Data as of

Dec 2021
Most recent filing

Oxford BioMedica PLC Cash Flow Quality Index (2018–2021)

Historical Cash Flow Quality Index for Oxford BioMedica PLC across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Oxford BioMedica PLC tangible equity quality to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Oxford BioMedica PLC (2018–2021)

Year-by-year earnings quality comparison for Oxford BioMedica PLC. For live market cap and the full company financial profile, see OXB market cap overview.

Year Quality Index Operating CF (GBX) Net Income YoY Change
2021 1.28x GBX25.45 Million GBX19.88 Million ▲ +38.5%
2018 0.92x GBX12.87 Million GBX13.91 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.